These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6676929)

  • 41. Application of proteomic technology in identifying pancreatic secretory trypsin inhibitor variants in urine of patients with pancreatitis.
    Valmu L; Paju A; Lempinen M; Kemppainen E; Stenman UH
    Clin Chem; 2006 Jan; 52(1):73-81. PubMed ID: 16254194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transgenic expression of pancreatic secretory trypsin inhibitor-I ameliorates secretagogue-induced pancreatitis in mice.
    Nathan JD; Romac J; Peng RY; Peyton M; Macdonald RJ; Liddle RA
    Gastroenterology; 2005 Mar; 128(3):717-27. PubMed ID: 15765407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol.
    Playford RJ; Batten JJ; Freeman TC; Beardshall K; Vesey DA; Fenn GC; Baron JH; Calam J
    Gut; 1991 Nov; 32(11):1396-400. PubMed ID: 1752476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A mutant trypsin-like enzyme from Streptomyces fradiae, created by site-directed mutagenesis, improves affinity chromatography for protein trypsin inhibitors.
    Katoh T; Kikuchi N; Nagata K; Yoshida N
    Appl Microbiol Biotechnol; 1996 Aug; 46(1):15-21. PubMed ID: 8987530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Local administration of human pancreatic secretory trypsin inhibitor prevents the development of experimental acute pancreatitis in rats and dogs.
    Ohlsson K; Olsson R; Björk P; Balldin G; Borgström A; Lasson A; Kohno T; Thompson RC
    Scand J Gastroenterol; 1989 Aug; 24(6):693-704. PubMed ID: 2814337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The elimination in dogs of trypsin-alpha-macroglobulin complexes inactivated by the Kazal or the Kunitz inhibitor.
    Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1978 Mar; 359(3):379-84. PubMed ID: 76602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biology and function of tumor-associated trypsin inhibitor, TATI.
    Stenman UH; Koivunen E; Itkonen O
    Scand J Clin Lab Invest Suppl; 1991; 207():5-9. PubMed ID: 1780691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Site-directed mutagenesis of human pancreatic secretory trypsin inhibitor.
    Kikuchi N; Nagata K; Shin M; Mitsushima K; Teraoka H; Yoshida N
    J Biochem; 1989 Dec; 106(6):1059-63. PubMed ID: 2628423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis.
    Hirota M; Ohmuraya M; Baba H
    J Gastroenterol; 2006 Sep; 41(9):832-6. PubMed ID: 17048046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Experimental studies on the significance of the measurement of serum pancreatic secretory trypsin inhibitor in acute pancreatitis].
    Tanaka T; Yamamoto M; Okumura S; Oyanagi H; Saitoh Y
    Nihon Shokakibyo Gakkai Zasshi; 1985 Aug; 82(8):1914-23. PubMed ID: 4068313
    [No Abstract]   [Full Text] [Related]  

  • 51. [Basic and clinical evaluation of pancreatic secretory trypsin inhibitor (PSTI) radioimmunoassay kit].
    Fukushi M; Suzuki K; Kuramoto M; Kondo T; Nogami S; Hara Y; Sakai S; Ookubo A; Tabata I; Onodera T
    Radioisotopes; 1984 May; 33(5):295-8. PubMed ID: 6473842
    [No Abstract]   [Full Text] [Related]  

  • 52. Extrapancreatic origin of the pancreatic secretory trypsin inhibitor as an acute-phase reactant.
    Jönsson P; Linder C; Genell S; Ohlsson K
    Pancreas; 1996 Apr; 12(3):303-7. PubMed ID: 8830339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Basic and clinical studies on radioimmunoassay of pancreatic secretory trypsin inhibitor (PSTI)].
    Noritake M; Haga H; Katsurada M; Kihara A
    Kaku Igaku; 1985 Sep; 22(9):1413-8. PubMed ID: 4087561
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pancreatic secretory trypsin inhibitor in urothelial cancer].
    Tashiro K; Torii S; Iwamuro S; Ohishi Y; Hasegawa N; Kawashima Y; Mochizuki A; Yoshigoe H; Wada T; Machida T
    Hinyokika Kiyo; 1989 Oct; 35(10):1659-63. PubMed ID: 2610172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The diagnostic significance of pancreatic secretory trypsin inhibitor (PSTI) in patients with gynecologic tumors].
    Inoue M; Inoue Y; Ueda G; Matsuda K; Ogawa M; Mori T
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2225-9. PubMed ID: 6533205
    [No Abstract]   [Full Text] [Related]  

  • 56. Human mesotrypsin defies natural trypsin inhibitors: from passive resistance to active destruction.
    Sahin-Tóth M
    Protein Pept Lett; 2005 Jul; 12(5):457-64. PubMed ID: 16029158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific binding of human pancreatic secretory trypsin inhibitor to various cultured cells.
    Niinobu T; Ogawa M; Shibata T; Murata A; Nishibe S; Mori T; Ogata N
    Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):245-8. PubMed ID: 3489966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Changes in serum pancreatic secretory trypsin inhibitor (PSTI) during and after heart surgery].
    Andoh T; Doi H; Kitamura S; Suzuki H; Okutsu Y
    Kokyu To Junkan; 1989 Jan; 37(1):71-6. PubMed ID: 2734496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Significance of pancreatic secretory trypsin inhibitor analysis in clinical tests].
    Ogawa M
    Nihon Rinsho; 1989 Dec; 48 Suppl():356-9. PubMed ID: 2621901
    [No Abstract]   [Full Text] [Related]  

  • 60. Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases.
    Plebani M; Basso D; Fabris C; Meggiato T; Del Favero G; Panozzo MP; Fogar P; Faggian D; Angonese C; Burlina A
    Klin Wochenschr; 1989 Oct; 67(20):1029-32. PubMed ID: 2586008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.